
这个市场不适合进入。 结论很明确:当前只有 1 个新品牌 JEXINOVIX,2 个新发布里只有 1 个能验证盈利,表面成功率 50%,但样本太小,不能说明机会健康;更关键的是,真正跑通的只有 B0FGWGQ8RQ 这一款,说明这是“单品成功”而不是“多品牌可复制”。
证据上,市场不是红利型,而是低利润、靠差异化硬打的窄窗口。 B0FGWGQ8RQ 售价 $13.56,毛利率 15.33%,月销约 100 件,月收入约 $13,560;它的成功驱动是“基于旧款做功能改良、低价、附带不同长度螺丝降低安装门槛”。这说明小卖家如果没有明确功能升级和更强供应链,很难复制。并且 JEXINOVIX 作为唯一可见成功品牌,只有这 1 个可盈利新品,另 1 个产品盈利状态还无法确认,品牌层面也看不出稳定扩张能力。市场里没有看到 30+ 新品牌涌入的那种明显过热信号,但也没有看到足够多的成功样本来支持“可持续进入”。
对大品牌来说,预算不是最大问题,真正问题是要接受靠产品更新、设计差异或品牌投入去换结果,而不是靠市场本身;对小品牌来说,这里不是好市场,现有成功样本的 15.33% 利润只能算及格线,且还没算长期研发、品牌和认证成本。短结论:不要推进。 如果强行进入,至少要做到比 B0FGWGQ8RQ 更强的功能差异和更稳的获客能力,否则胜率不够。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个适合进入的市场。 现有样本里只有 1 个可盈利新品牌 JEXINOVIX,且其成功并不代表市场宽松,反而显示赢家极少、进入门槛高;更关键的是,B0FGWGQ8RQ 这类能跑通的款,早期投入约 2514.12 美元,而且这还没算长期 R&D、品牌和认证成本。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场目前只看到一个可复制的成功样本,但样本极少,不能证明市场健康;更重要的是,公开数据里没有出现足够的新品牌大规模涌入,也没有看到低于10%利润率占主导的价格战信号。 现在的结论是:可以谨慎看,但还不能把它当成“容易进入”的市场;对小品牌来说,只有做出明显功能差异化才有机会,纯跟卖不值得进。
这个市场不该进入。 目前看到的有效样本里,利润结构太薄,而且新入场品牌几乎只有一个可验证案例;这不是健康增长市场,更像是靠单品爆发撑起来的窄机会。
证据很直接:JEXINOVIX 作为新品牌,只有 1 个可盈利新品 B0FGWGQ8RQ,利润率 15.33%,月销约 100 件、月收入约 $13,560,但同时还有 1 个产品处于“无法判断盈利”的状态,说明它并不是稳定复制型打法。 该品牌总收入约 $135,600,而可识别预算数据为空,意味着真实入场成本不透明;更关键的是,当前已知的利润分布里,全部和新品样本都集中在 10%~20% 区间,没有任何高利润护城河,说明市场本身没有给出足够宽的利润空间。对小卖家来说,唯一能算“可参考”的成功样本就是 B0FGWGQ8RQ,但这类 15% 左右利润只能算及格线,不足以支撑高失误率的测试成本;对大品牌来说,虽然资金上“可以做”,但也必须接受靠品牌力、产品创新或额外投入去换结果,而不是靠市场红利。
结论:小卖家没有清晰、可复制的成功路径;大品牌也不是好市场,只能重投入硬打。 目前没有证据显示该类目已被 30+ 新品牌淹没,但现有数据更像“低利润、单品驱动、胜率有限”的市场,入场风险偏高。建议你不要推进,除非你能明确做出比现有样本更强的差异化,并且预算足以覆盖长期品牌和创新成本;否则这类市场对小卖家和大品牌都不是好机会。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FGWGQ8RQ | JEXINOVIX | 2025-08-23 | Yes | $13.56 | 100pcs | $1356.0 | 15.33% | $207.88 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FGWGQ8RQ | JEXINOVIX | 2025-08-23 | Yes | $13.56 | 100pcs | $1356.0 | 15.33% | $207.88 |
这个市场目前不适合进入。 关键问题不是“有没有利润”,而是只有一个可验证样本,且市场信号极度集中:全部可见的盈利都来自同一个新品牌 JEXINOVIX 的单个 ASIN B0FGWGQ8RQ,说明这不是一个已经形成多品牌机会的市场,更像是单点成功案例,无法支持大规模复制。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
这个市场不值得现在进入,整体已经接近或进入过热竞争区。 目前只看到 1 个新品牌 JEXINOVIX 的新品牌成功样本,表面成功率是 50%,但这只是 2 个新发布产品里的 1 个成功,样本太小,不能当成可复制机会;更关键的是,成功路径明显依赖低价、旧款改良和强营销,不是轻松复制的蓝海。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |